THERAPEUTIC CLASS
Targeted Deletion of the Sclerostin Gene in Mice Results in Increase Bone Formation and Bone Strength
Sclerosteosis is a rare high bone mass genetic disorder in humans caused by inactivating mutations
in SOST, the gene encoding sclerostin. Based on these data, sclerostin has emerged as a key negative
regulator of bone mass. We generated SOST knockout (KO) mice to gain a more detailed understanding of
the effects of sclerostin deficiency on bone
No other version available